Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00048737
Status:
COMPLETED
Last Update Posted:
2013-06-13
First Post:
2002-11-06
Brief Title:
Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| ASCT | View |
| Leukemia | View |
| Lymphoma | View |
| Lymphoid Malignancy | View |
| Cyclophosphamide | View |
| Cytoxan | View |
| Neosar | View |
| Fludarabine | View |
| Fludarabine Phosphate | View |
| Fludara | View |
| Rituximab | View |
| Rituxan | View |
| Zevalin | View |
| Indium Zevalin | View |
| 90Y Zevalin | View |
| CD-20-positive | View |
| B-cell Lymphoma | View |
| CD-20-positive B-cell Lymphoma | View |
| NHL | View |
| CLL | View |
| Chronic Lymphocytic Leukemia | View |
| Allogeneic Stem Cell Transplantation | View |